Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEPH

Nephros Inc

Dec 01 • 04:00PM ET

2.21

Dollar change -0.08
Percentage change -3.49	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.18	Insider Own	11.54%	Shs Outstand	10.30M	Perf Week	-1.78%
Market Cap	23.16M	Forward P/E	-	EPS next Y	-0.04	Insider Trans	0.17%	Shs Float	9.27M	Perf Month	29.22%
Income	-1.84M	PEG	-	EPS next Q	-0.03	Inst Own	40.91%	Short Float / Ratio	0.27% / 2.62	Perf Quarter	31.16%
Sales	13.54M	P/S	1.71	EPS this Y	72.62%	Inst Trans	1.00%	Short Interest	0.02M	Perf Half Y	78.23%
Book/sh	0.82	P/B	2.69	EPS next Y	65.22%	ROA	-15.37%	Target Price	4.50	Perf Year	121.00%
Cash/sh	0.44	P/C	5.01	EPS next 5Y	-	ROE	-22.92%	52W Range	0.95 - 2.50	Perf YTD	90.98%
Dividend	-	P/FCF	19.46	EPS past 5Y	-39.13%	ROI	-20.23%	52W High	-11.60%	Beta	1.28
Dividend %	-	Quick Ratio	3.41	Sales past 5Y	26.17%	Gross Margin	56.42%	52W Low	132.63%	ATR	0.13
Employees	27	Current Ratio	4.65	Sales Q/Q	55.33%	Oper. Margin	-12.09%	RSI (14)	65.44	Volatility	4.98% 6.79%
Optionable	No	Debt/Eq	0.09	EPS Q/Q	94.45%	Profit Margin	-13.58%	Rel Volume	0.51	Prev Close	2.29
Shortable	Yes	LT Debt/Eq	0.05	Earnings	Nov 08 AMC	Payout	-	Avg Volume	9.43K	Price	2.21
Recom	2.00	SMA20	8.35%	SMA50	24.72%	SMA200	48.57%	Volume	4,826	Change	-3.49%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-26-21	Initiated	B. Riley Securities	Buy	$12.50

Nov-11-23 12:41PM	Nephros, Inc. (NASDAQ:NEPH) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 04:15PM	Nephros Announces Results for Quarter Ended September 30, 2023 (GlobeNewswire) +11.49%
Nov-01-23 07:30AM	Nephros Hires Judy Krandel as Chief Financial Officer (GlobeNewswire)
Oct-25-23 07:30AM	Nephros Schedules Third Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Sep-19-23 04:30PM	Nephros to Present at LD Micro Main Event XVI (Newsfile)
04:15PM	Loading…
Aug-09-23 04:15PM	Nephros Announces Results for Quarter Ended June 30, 2023 (GlobeNewswire)
Jul-26-23 07:30AM	Nephros Schedules Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
May-24-23 07:30AM	Nephros to Present at LD Micro Invitational XIII (Newsfile)
May-10-23 04:15PM	Nephros Announces Results for Quarter Ended March 31, 2023 (GlobeNewswire)
May-08-23 07:30AM	Nephros Announces CEO Retirement and Succession Plan (GlobeNewswire)
Apr-26-23 07:30AM	Nephros Schedules First Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Apr-04-23 07:30AM	Nephros Announces Preliminary Results for First Quarter 2023 (GlobeNewswire) +14.07%
Mar-08-23 04:15PM	Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results (GlobeNewswire) -6.60%
Mar-01-23 04:30PM	Nephros and Donastar Announce Strategic Partnership (GlobeNewswire)
Feb-22-23 04:30PM	Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call (GlobeNewswire) -6.50%
07:30AM	Loading…
Jan-11-23 07:30AM	Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2022 (GlobeNewswire)
Nov-02-22 04:15PM	Nephros Announces Results for Quarter Ended September 30, 2022 (GlobeNewswire)
Oct-19-22 07:30AM	Nephros Third Quarter 2022 Financial Results Conference Call (GlobeNewswire)
Oct-12-22 07:30AM	Nephros to Present at LD Micro Main Event XV (Newsfile)
Oct-11-22 07:30AM	Nephros Announces Agreement to Sell Pathogen Detection Systems Business and Preliminary Results for Quarter Ended September 30, 2022 (GlobeNewswire)
Sep-28-22 07:30AM	Nephros Partners with Donastar and Tractor Beverage Company to Supply and Service Nationwide Fast-Casual Restaurant Operation (GlobeNewswire)
Sep-08-22 04:00PM	Nephros Appoints Joe Harris to Its Board of Directors (GlobeNewswire)
Aug-13-22 08:22AM	Nephros, Inc. (NASDAQ:NEPH) Just Reported Earnings, And Analysts Cut Their Target Price (Simply Wall St.)
Aug-10-22 04:15PM	Nephros Announces Results for Quarter Ended June 30, 2022 (GlobeNewswire)
Jul-27-22 07:30AM	Nephros Second Quarter 2022 Financial Results Conference Call (GlobeNewswire) +6.90%
Jul-06-22 07:30AM	Nephros Announces Preliminary Results for Quarter Ended June 30, 2022 and Projects Positive Net Cash Flow in 12 Months (GlobeNewswire)
May-17-22 07:30AM	Nephros Receives FDA 510(k) Clearance for HDF Assist Module (GlobeNewswire) -12.78%
May-04-22 04:15PM	Nephros Announces Results for Quarter Ended March 31, 2022 (GlobeNewswire) +6.78%
Apr-27-22 07:30AM	Nephros First Quarter 2022 Financial Results Conference Call (GlobeNewswire)
Apr-26-22 07:30AM	Nephros Unveils New Branding and Website (GlobeNewswire)
07:30AM	Loading…
Mar-21-22 07:30AM	Nephros to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest (GlobeNewswire)
Feb-28-22 07:30AM	Nephros to Present at Q1 Virtual Investor Summit (Newsfile)
Feb-23-22 04:15PM	Nephros Announces Fourth Quarter and Fiscal Year 2021 Financial Results (GlobeNewswire)
Feb-09-22 07:30AM	Nephros Fourth Quarter 2021 Financial Results Conference Call (GlobeNewswire) +6.98%
Jan-13-22 07:30AM	Nephros Issues 2022 Shareholder Letter (GlobeNewswire)
Jan-11-22 07:30AM	Nephros Announces Preliminary Results for Fourth Quarter and Fiscal Year 2021 and Revenue Guidance for 2022 (GlobeNewswire)
Nov-23-21 04:15PM	Nephros to Present at the Benchmark Company 10th Annual One-on-One Discovery Conference (GlobeNewswire)
Nov-08-21 07:30AM	Nephros to Present at the Q4 Virtual Investor Summit (Newsfile)
Nov-04-21 04:15PM	Nephros Announces Results for Quarter Ended September 30, 2021 (GlobeNewswire)
Oct-21-21 07:30AM	Nephros Announces Third Quarter 2021 Financial Results Conference Call (GlobeNewswire)
Oct-08-21 07:30AM	Nephros Announces Preliminary Results for Third Quarter of 2021 (GlobeNewswire)
Oct-05-21 07:30AM	Nephros to Present at the LD Micro Main Event (GlobeNewswire)
Sep-15-21 09:39AM	Nephros to Present at the Virtual MicroCap Leadership Summit (GlobeNewswire) +8.35%
Sep-06-21 11:42AM	Bullish insiders bet US$699k on Nephros, Inc. (NASDAQ:NEPH) (Simply Wall St.)
Sep-01-21 07:30AM	Nephros Appoints Wes Lobo to Chief Commercial Officer (GlobeNewswire)
Aug-05-21 04:15PM	Nephros Announces Results for Quarter Ended June 30, 2021 (GlobeNewswire)
Jul-28-21 03:03PM	Will Nephros Inc. (NEPH) Report Negative Q2 Earnings? What You Should Know (Zacks)
Jul-12-21 07:30AM	Nephros Announces Acquisition of GenArraytion, Inc. (GlobeNewswire)
Jul-09-21 04:18PM	Nephros CEO Presenting at Access to Giving Virtual Investor Conference (GlobeNewswire)
Jul-08-21 11:20AM	50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 (ACCESSWIRE) -8.82%
07:30AM	Nephros Announces Preliminary Results for Second Quarter of 2021 (GlobeNewswire)
05:07AM	Did Business Growth Power Nephros' (NASDAQ:NEPH) Share Price Gain of 227%? (Simply Wall St.)
Jun-29-21 08:50AM	Here's What Could Help Nephros Inc. (NEPH) Maintain Its Recent Price Strength (Zacks) +13.77%
Jun-23-21 09:35AM	50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021 (ACCESSWIRE)
May-31-21 08:50AM	What Makes Nephros Inc. (NEPH) a Good Fit for "Trend Investing" (Zacks)
May-06-21 04:15PM	Nephros Announces Results for Quarter Ended March 31, 2021 (GlobeNewswire)
02:45PM	Nephros, Inc. to Host Earnings Call (ACCESSWIRE)
Apr-26-21 07:30AM	Nephros Announces First Quarter 2021 Financial Results Conference Call (GlobeNewswire)
Apr-09-21 05:29AM	A Look At The Fair Value Of Nephros, Inc. (NASDAQ:NEPH) (Simply Wall St.)
Apr-05-21 07:30AM	Nephros Announces Preliminary Results for First Quarter of 2021 (GlobeNewswire) +21.63%
Mar-16-21 07:45AM	Nephros to Present at the Q1 Virtual Investor Summit (GlobeNewswire)
Mar-10-21 07:30AM	Nephros to Participate in M-Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference (GlobeNewswire)
Mar-04-21 02:07AM	Why Nephros, Inc. (NASDAQ:NEPH) Could Be Worth Watching (Simply Wall St.) -7.84%
Mar-01-21 04:15PM	Nephros Reports 2020 Fourth Quarter and Full Year Financial Results (GlobeNewswire) +6.36%
02:30PM	Nephros, Inc. to Host Earnings Call (ACCESSWIRE)
Feb-22-21 07:30AM	Nephros Announces Fourth Quarter and Full Year 2020 Financial Results Conference Call (GlobeNewswire)
Feb-18-21 07:30AM	Nephros Hires Wes Lobo as Chief Marketing Officer (GlobeNewswire)
Jan-22-21 02:21AM	The Nephros (NASDAQ:NEPH) Share Price Is Up 128% And Shareholders Are Boasting About It (Simply Wall St.)
Jan-12-21 07:30AM	Nephros Announces Preliminary Financial Results for Fourth Quarter and Fiscal Year 2020 (GlobeNewswire)
Jan-05-21 10:55AM	Update: Nephros Provides Year-End Technology Update, Including HDF Program Status (GlobeNewswire)
Jan-04-21 07:30AM	Nephros Provides Year-End Technology Update, Including HDF Program Status (GlobeNewswire) -7.23%
Nov-29-20 09:33AM	Where Do Hedge Funds Stand On Nephros, Inc. (NEPH)? (Insider Monkey)
Nov-19-20 06:45AM	Sidoti Virtual Microcap Investor Conference (ACCESSWIRE)
Nov-09-20 07:30AM	Nephros to Present at Three November Investment Conferences (GlobeNewswire)
Nov-05-20 04:27PM	Nephros Appoints Dan DAgostino as CFO and Reports Third Quarter Financial Results (GlobeNewswire)
02:30PM	Nephros, Inc. to Host Earnings Call (ACCESSWIRE)
Oct-29-20 07:30AM	Nephros Announces Third Quarter 2020 Financial Results Conference Call (GlobeNewswire)
Oct-24-20 10:47AM	Sandra Pessin of Nephros, Inc. (NASDAQ:NEPH) Just Spent US$300k On Shares (Simply Wall St.)
Oct-16-20 07:30AM	Nephros Announces Pricing of $5 Million Registered Direct Offering of Common Stock (GlobeNewswire)
Oct-13-20 07:30AM	Nephros Announces Release of DialyPath, a qPCR-based, Real-time, On-site Endotoxin Assay for Dialysis Water (GlobeNewswire)
Oct-07-20 07:30AM	Nephros to Present at MicroCap Rodeo Best Ideas Bowl on October 13th at 11:30 AM ET (GlobeNewswire)
Oct-06-20 07:30AM	Nephros Announces Preliminary Third Quarter Revenues of $2.1 Million (GlobeNewswire)
Aug-31-20 05:00PM	(LD Micro) 360 Companies Set to Present this Week (ACCESSWIRE)
Aug-25-20 07:30AM	Nephros to Present at the LD 500 Virtual Conference (ACCESSWIRE)
Aug-14-20 07:30AM	Nephros Names Andy Astor President and Chief Executive Officer (GlobeNewswire)
Aug-06-20 01:43PM	LD Micro: Announces Preliminary List of Presenters for the LD-500 (ACCESSWIRE)
Aug-05-20 04:15PM	Nephros Reports Second Quarter Financial Results (GlobeNewswire)
Jul-29-20 07:30AM	Nephros Announces Second Quarter 2020 Financial Results Conference Call (GlobeNewswire)
Jul-22-20 07:30AM	Potable Water in Buildings Unoccupied During COVID-19 Pandemic Contains Far More Bacteria than in Occupied Buildings; Legionella does not Predominate (GlobeNewswire)
Jul-16-20 11:00AM	'Zooming with LD' to Feature 10 Distinct Companies July 20th-31st (ACCESSWIRE)
Jul-14-20 07:30AM	Analysts Are More Bearish On Nephros, Inc. (NASDAQ:NEPH) Than They Used To Be (Simply Wall St.)
Jul-13-20 07:30AM	Nephros to Present at Zooming with LD (GlobeNewswire)
Jul-08-20 07:30AM	Nephros Announces Preliminary Financial Results for Second Quarter 2020 (GlobeNewswire) -6.95%
Jun-18-20 07:30AM	Nephros Set to Join Russell Microcap® Index (GlobeNewswire)
Jun-10-20 01:44PM	Hedge Funds Getting Bullish On Nephros, Inc. (NEPH) (Insider Monkey)
Jun-03-20 09:00AM	47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th (ACCESSWIRE)
Jun-02-20 07:30AM	Nephros to Present at the Virtual Summer Summit (GlobeNewswire)
May-11-20 04:15PM	Nephros, Inc. to Hold Virtual Annual Meeting of Stockholders (GlobeNewswire) -7.54%
May-06-20 04:15PM	Nephros Reports First Quarter Financial Results (GlobeNewswire) +7.70%
Apr-29-20 07:30AM	Nephros Announces First Quarter 2020 Financial Results Conference Call (GlobeNewswire)

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration, Pathogen Detection and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Pathogen Detection segment develops and sells portable, real-time water testing systems designed to provide actionable data on waterborne pathogens in approximately one hour. The Renal Products segment consists of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate, and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Banks Robert R. Jr.	President and CEO	Aug 15	Buy	1.69	1,901	3,207	2,000	Aug 15 04:15 PM
Banks Robert R. Jr.	President and CEO	Aug 14	Buy	1.50	99	148	99	Aug 15 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NEPH

Nephros Inc

Upgrade your FINVIZ experience